TY - JOUR
T1 - Digital measures of freezing of gait across the spectrum of normal, non-freezers, possible freezers and definite freezers
AU - Mancini, Martina
AU - Hasegawa, Naoya
AU - Peterson, Daniel S.
AU - Horak, Fay B.
AU - Nutt, John G.
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
PY - 2023/9
Y1 - 2023/9
N2 - Over the course of the disease, freezing of gait (FoG) will gradually impact over 80% of people with Parkinson’s disease (PD). Clinical decision-making and research design are often based on classification of patients as ‘freezers’ or ‘non-freezers’. We derived an objective measure of FoG severity from inertial sensors on the legs to examine the continuum of FoG from absent to possible and severe in people with PD and in healthy controls. One hundred and forty-seven people with PD (Off-medication) and 83 healthy control subjects turned 360° in-place for 1 minute while wearing three wearable sensors used to calculate a novel Freezing Index. People with PD were classified as: ‘definite freezers’, new FoG questionnaire (NFOGQ) score > 0 and clinically observed FoG; ‘non-freezers’, NFOGQ = 0 and no clinically observed FoG; and ‘possible freezers’, either NFOGQ > 0 but no FoG observed or NFOGQ = 0 but FoG observed. Linear mixed models were used to investigate differences in participant characteristics among groups. The Freezing Index significantly increased from healthy controls to non-freezers to possible freezers and to definite freezers and showed, in average, excellent test–retest reliability (ICC = 0.89). Unlike the Freezing Index, sway, gait and turning impairments were similar across non-freezers, possible and definite freezers. The Freezing Index was significantly related to NFOG-Q, disease duration, severity, balance confidence, and the SCOPA-Cog (p < 0.01). An increase in the Freezing Index, objectively assessed with wearable sensors during a turning- in-place test, may help identify prodromal FoG in people with PD prior to clinically-observable or patient-perceived freezing. Future work should follow objective measures of FoG longitudinally.
AB - Over the course of the disease, freezing of gait (FoG) will gradually impact over 80% of people with Parkinson’s disease (PD). Clinical decision-making and research design are often based on classification of patients as ‘freezers’ or ‘non-freezers’. We derived an objective measure of FoG severity from inertial sensors on the legs to examine the continuum of FoG from absent to possible and severe in people with PD and in healthy controls. One hundred and forty-seven people with PD (Off-medication) and 83 healthy control subjects turned 360° in-place for 1 minute while wearing three wearable sensors used to calculate a novel Freezing Index. People with PD were classified as: ‘definite freezers’, new FoG questionnaire (NFOGQ) score > 0 and clinically observed FoG; ‘non-freezers’, NFOGQ = 0 and no clinically observed FoG; and ‘possible freezers’, either NFOGQ > 0 but no FoG observed or NFOGQ = 0 but FoG observed. Linear mixed models were used to investigate differences in participant characteristics among groups. The Freezing Index significantly increased from healthy controls to non-freezers to possible freezers and to definite freezers and showed, in average, excellent test–retest reliability (ICC = 0.89). Unlike the Freezing Index, sway, gait and turning impairments were similar across non-freezers, possible and definite freezers. The Freezing Index was significantly related to NFOG-Q, disease duration, severity, balance confidence, and the SCOPA-Cog (p < 0.01). An increase in the Freezing Index, objectively assessed with wearable sensors during a turning- in-place test, may help identify prodromal FoG in people with PD prior to clinically-observable or patient-perceived freezing. Future work should follow objective measures of FoG longitudinally.
KW - Freezing of gait
KW - Gait
KW - Parkinson’s disease
KW - Wearable technology
UR - http://www.scopus.com/inward/record.url?scp=85159692802&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159692802&partnerID=8YFLogxK
U2 - 10.1007/s00415-023-11773-4
DO - 10.1007/s00415-023-11773-4
M3 - Article
C2 - 37208526
AN - SCOPUS:85159692802
SN - 0340-5354
VL - 270
SP - 4309
EP - 4317
JO - Journal of Neurology
JF - Journal of Neurology
IS - 9
ER -